PROCLAIM: A Phase III Study of Pemetrexed, Cisplatin, and Radiation Therapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiation Therapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Locally Advanced Stage III Non–Small-Cell Lung Cancer of Other than Predominantly Squamous Cell Histology

PROCLAIM Phase III Study

Everett E. Vokes; Suresh Senan; Joseph A. Treat; Neill A. Iscoe

Disclosures

Clin Lung Cancer. 2009;10(3):193-198. 

In This Article

Statistical Considerations

A total of 600 patients will be randomized equally between the 2 arms. This will provide a minimum power of 80% to detect an HR of 0.74 at a 2-sided type-one error rate of 5%.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....